This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Leland Stanford Junior University. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Frederick Tomlin: Innovator in Cancer Treatment
Introduction
Frederick Tomlin is a notable inventor based in Stanford, California. He has made significant contributions to the field of cancer treatment through his innovative research and patent work. His dedication to advancing medical science has positioned him as a key figure in his area of expertise.
Latest Patents
Frederick Tomlin holds a patent for "Agents that inhibit NGLY1 and methods of use thereof." This patent outlines methods for the treatment of cancer cells by contacting them with an inhibitor on NGLY1, optionally in combination with a direct proteasome inhibitor. This innovative approach has the potential to enhance cancer treatment strategies.
Career Highlights
Tomlin is affiliated with Leland Stanford Junior University, where he conducts his research and collaborates with other experts in the field. His work has garnered attention for its potential impact on cancer therapies and has contributed to the broader understanding of cancer cell biology.
Collaborations
Frederick Tomlin has worked alongside esteemed colleagues, including Carolyn Ruth Bertozzi and Ulla Gerling-Driessen. These collaborations have enriched his research and fostered a dynamic environment for innovation.
Conclusion
Frederick Tomlin's contributions to cancer treatment through his patent and research at Leland Stanford Junior University highlight his role as an influential inventor. His work continues to inspire advancements in medical science and cancer therapies.